The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Herpesvirus 1, Cercopithecine

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Herpesvirus 1, Cercopithecine

  • We describe severe and unexpected multisystem toxicity that occurred during a study of the antiviral nucleoside analogue fialuridine (1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil, or FIAU) as therapy for chronic hepatitis B virus infection [1].
  • The discovery that group B adenoviruses use CD46, a ubiquitously expressed complement regulatory protein, as a cellular attachment receptor elucidates the diverse clinical manifestation of group B virus infections, and bears directly on the application of these vectors for gene therapy [2].
  • Effect of vidarabine on chronic hepatitis B virus infection [3].
  • The salient facts which have emerged from our study of Abelson virus (MuLV-A)lymphomagenesis in mice are that lymphoma induction is (a) age dependent, (b) virus dose dependent, and (c) under the control of host genes unrelated to other genes known to control murine leukemia (e.g., Fv-1 on Fv-2) [4].
  • Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma [5].

High impact information on Herpesvirus 1, Cercopithecine


Chemical compound and disease context of Herpesvirus 1, Cercopithecine


Biological context of Herpesvirus 1, Cercopithecine


Anatomical context of Herpesvirus 1, Cercopithecine

  • Viral sequence and host immune response were investigated in an unusual, asymptomatic chronic hepatitis B virus carrier (human leukocyte antigen type A24, Bw61, Bw62, Bw6, DRw11, DRw52, DQw7) who was consistently nonreactive for antibody to HBc and had a normal ALT level over a 5-yr study period [19].
  • The nature of the oligosaccharide chains of the major envelope glycoprotein, gp85, from avian myeloblastosis-associated viruses has been examined for the subgroup A and subgroup B viruses replicated in fibroblasts from the same chicken embryos [20].
  • The anti-hepatitis B virus (HBV) activity of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) in cultures of primary human hepatocytes was examined [21].
  • The polymerase chain reaction demonstrated presence of the ICP 18.5 (UL28) gene of B virus in neuronal tissues of 15 monkeys presumed to be latently infected, including 12.8% of trigeminal and 22.9% of lumbosacral ganglia pools [22].
  • Although 1.6 +/- 0.8% of American donor CD8 T cells produced IFN-gamma above the background level in response to IIIB virus, 1.5 +/- 0.8% responded to B' virus, and 1.4 +/- 0.7% responded to C/B' virus [23].

Gene context of Herpesvirus 1, Cercopithecine


Analytical, diagnostic and therapeutic context of Herpesvirus 1, Cercopithecine


  1. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. McKenzie, R., Fried, M.W., Sallie, R., Conjeevaram, H., Di Bisceglie, A.M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C. N. Engl. J. Med. (1995) [Pubmed]
  2. CD46 is a cellular receptor for group B adenoviruses. Gaggar, A., Shayakhmetov, D.M., Lieber, A. Nat. Med. (2003) [Pubmed]
  3. Effect of vidarabine on chronic hepatitis B virus infection. Pollard, R.B., Smith, J.L., Neal, A., Gregory, P.B., Merigan, T.C., Robinson, W.S. JAMA (1978) [Pubmed]
  4. Abelson virus-induced lymphomagenesis in mice. Risser, R., Potter, M., Rowe, W.P. J. Exp. Med. (1978) [Pubmed]
  5. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Sheu, J.C., Huang, G.T., Shih, L.N., Lee, W.C., Chou, H.C., Wang, J.T., Lee, P.H., Lai, M.Y., Wang, C.Y., Yang, P.M. Gastroenterology (1992) [Pubmed]
  6. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. Hayden, F.G., Osterhaus, A.D., Treanor, J.J., Fleming, D.M., Aoki, F.Y., Nicholson, K.G., Bohnen, A.M., Hirst, H.M., Keene, O., Wightman, K. N. Engl. J. Med. (1997) [Pubmed]
  7. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Ding, Q., Xia, W., Liu, J.C., Yang, J.Y., Lee, D.F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., Bargou, R.C., Qin, J., Lai, C.C., Tsai, F.J., Tsai, C.H., Hung, M.C. Mol. Cell (2005) [Pubmed]
  8. Inactivation of S-adenosylhomocysteine hydrolase during adenine arabinoside therapy. Sacks, S.L., Merigan, T.C., Kaminska, J., Fox, I.H. J. Clin. Invest. (1982) [Pubmed]
  9. Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis. Chisari, F.V., Routenberg, J.A., Fiala, M., Edgington, T.S. J. Clin. Invest. (1977) [Pubmed]
  10. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Kazim, S.N., Wakil, S.M., Khan, L.A., Hasnain, S.E., Sarin, S.K. Lancet (2002) [Pubmed]
  11. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Marinos, G., Naoumov, N.V., Rossol, S., Torre, F., Wong, P.Y., Gallati, H., Portmann, B., Williams, R. Gastroenterology (1995) [Pubmed]
  12. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Teare, J.P., Sherman, D., Greenfield, S.M., Simpson, J., Bray, G., Catterall, A.P., Murray-Lyon, I.M., Peters, T.J., Williams, R., Thompson, R.P. Lancet (1993) [Pubmed]
  13. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase. Kassianides, C., Hoofnagle, J.H., Miller, R.H., Doo, E., Ford, H., Broder, S., Mitsuya, H. Gastroenterology (1989) [Pubmed]
  14. Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit. Laing, P., Knight, J.G., Hill, J.M., Harris, A.G., Oxford, J.S., Webster, R.G., Markwell, M.A., Paul, S.M., Pert, C.B. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  15. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Lin, J.C., Lin, S.C., De, B.K., Chan, W.P., Evatt, B.L., Chan, W.C. Blood (1993) [Pubmed]
  16. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Vreugdenhil, G.R., Geluk, A., Ottenhoff, T.H., Melchers, W.J., Roep, B.O., Galama, J.M. Diabetologia (1998) [Pubmed]
  17. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. Matrosovich, M., Matrosovich, T., Carr, J., Roberts, N.A., Klenk, H.D. J. Virol. (2003) [Pubmed]
  18. Pathogenicity of different baboon herpesvirus papio 2 isolates is characterized by either extreme neurovirulence or complete apathogenicity. Rogers, K.M., Ealey, K.A., Ritchey, J.W., Black, D.H., Eberle, R. J. Virol. (2003) [Pubmed]
  19. Chronic hepatitis B virus infection in an anti-HBc-nonreactive blood donor: variant virus or defective immune response? Lee, J.H., Paglieroni, T.G., Holland, P.V., Zeldis, J.B. Hepatology (1992) [Pubmed]
  20. Comparison of the oligosaccharide moieties of the major envelope glycoproteins of the subgroup A and subgroup B avian myeloblastosis-associated viruses. Hunt, L.A., Wright, S.E. J. Virol. (1983) [Pubmed]
  21. (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes. Condreay, L.D., Condreay, J.P., Jansen, R.W., Paff, M.T., Averett, D.R. Antimicrob. Agents Chemother. (1996) [Pubmed]
  22. Risk of venereal B virus (cercopithecine herpesvirus 1) transmission in rhesus monkeys using molecular epidemiology. Weigler, B.J., Scinicariello, F., Hilliard, J.K. J. Infect. Dis. (1995) [Pubmed]
  23. Cross-clade CD8 T-cell responses to HIV(IIIB) and Chinese B' and C/B' viruses in North American and Chinese HIV-seropositive donors. François-Bongarcon, V., Feng, Y., Lee, S.K., Chen, G., Shankar, P., Liu, Y., Tao, X., Shao, Y., Lieberman, J. J. Acquir. Immune Defic. Syndr. (2004) [Pubmed]
  24. Interferon-gamma receptor expression in chronic hepatitis B virus infection. Lau, J.Y., Morris, A.G., Alexander, G.J., Williams, R. J. Hepatol. (1992) [Pubmed]
  25. Complete sequence and comparative analysis of the genome of herpes B virus (Cercopithecine herpesvirus 1) from a rhesus monkey. Perelygina, L., Zhu, L., Zurkuhlen, H., Mills, R., Borodovsky, M., Hilliard, J.K. J. Virol. (2003) [Pubmed]
  26. Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Yamashita, M., Krystal, M., Palese, P. Virology (1989) [Pubmed]
  27. Chronic hepatitis B virus carriers have low lymphoproliferative responses to HBsAg and reduced interleukin-2 synthesis. Nagaraju, K., Naik, S.R., Naik, S. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. (1998) [Pubmed]
  28. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Frisk, G., Friman, G., Tuvemo, T., Fohlman, J., Diderholm, H. Diabetologia (1992) [Pubmed]
  29. A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy. Keeling, P.J., Lukaszyk, A., Poloniecki, J., Caforio, A.L., Davies, M.J., Booth, J.C., McKenna, W.J. J. Am. Coll. Cardiol. (1994) [Pubmed]
  30. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675. Molla, A., Kati, W., Carrick, R., Steffy, K., Shi, Y., Montgomery, D., Gusick, N., Stoll, V.S., Stewart, K.D., Ng, T.I., Maring, C., Kempf, D.J., Kohlbrenner, W. J. Virol. (2002) [Pubmed]
  31. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Stott, E.J., Taylor, G., Ball, L.A., Anderson, K., Young, K.K., King, A.M., Wertz, G.W. J. Virol. (1987) [Pubmed]
  32. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Park, G.J., Katelaris, P.H., Jones, D.B., Seow, F., Lin, B.P., Le Couteur, D.G., Ngu, M.C. Aliment. Pharmacol. Ther. (2005) [Pubmed]
WikiGenes - Universities